Patents by Inventor Margit Jeschke

Margit Jeschke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTERLEUKIN-17 (IL-17) ANTAGONISTIC ANTIBODIES
    Publication number: 20230235038
    Abstract: An Interleukin-17 (IL-17) binding molecule, in particular an antibody to human IL-17, more preferably a human antibody to human IL-17 is provided, wherein the hypervariable regions of the heavy and light chains have amino acid sequences as defined, for use in the treatment of an IL-17 mediated disease or disorder, e.g. rheumatoid arthritis.
    Type: Application
    Filed: July 7, 2022
    Publication date: July 27, 2023
    Inventors: Franco E. Di Padova, Hermann GRAM, Hans Hofstetter, Margit Jeschke, Jean-Michel Rene Rondeau, Wim Van Den Berg
  • METHODS AND COMPOSITIONS FOR DETERMINING THE POTENCY OF A THERAPEUTIC CELLULAR COMPOSITION
    Publication number: 20210140975
    Abstract: This disclosure provides a potency assay for evaluating the potency of facilitating cells and/or alpha beta TCR+ T cells.
    Type: Application
    Filed: December 18, 2020
    Publication date: May 13, 2021
    Inventors: Suzanne T. Ildstad, Andreas Katopodis, Vladimir Senyukov, Margit Jeschke
  • IL-17 ANTAGONISTIC ANTIBODIES
    Publication number: 20190270804
    Abstract: An Interleukin-17 (IL-17) binding molecule, in particular an antibody to human IL-17, more preferably a human antibody to human IL-17 is provided, wherein the hypervariable regions of the heavy and light chains have amino acid sequences as defined, for use in the treatment of an IL-17 mediated disease or disorder, e.g. rheumatoid arthritis.
    Type: Application
    Filed: May 15, 2019
    Publication date: September 5, 2019
    Inventors: Franco E. Di Padova, Hermann Gram, Hans Hofstetter, Margit Jeschke, Jean-Michel Rene Rondeau, Wim Van Den Berg
  • IL-17 antagonistic antibodies
    Patent number: 10344084
    Abstract: An Interleukin-17 (IL-17) binding molecule, in particular an antibody to human IL-17, more preferably a human antibody to human IL-17 is provided, wherein the hypervariable regions of the heavy and light chains have amino acid sequences as defined, for use in the treatment of an IL-17 mediated disease or disorder, e.g. rheumatoid arthritis.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: July 9, 2019
    Assignee: Novartis AG
    Inventors: Franco E. Di Padova, Hermann Gram, Hans Hofstetter, Margit Jeschke, Jean-Michel Rene Rondeau, Wim Van Den Berg
  • METHODS AND COMPOSITIONS FOR DETERMINING THE POTENCY OF A THERAPEUTIC CELLULAR COMPOSITION
    Publication number: 20180252729
    Abstract: This disclosure provides a potency assay for evaluating the potency of facilitating cells and/or alpha beta TCR+ T cells.
    Type: Application
    Filed: March 6, 2018
    Publication date: September 6, 2018
    Inventors: Suzanne T. Ildstad, Andreas Katopodis, Vladimir Senyukov, Margit Jeschke
  • IL-17 Antagonistic Antibodies
    Publication number: 20170355762
    Abstract: An IL-17 binding molecule, in particular an antibody to human IL-17, more preferably a human antibody to human IL-17 is provided, wherein the hypervariable regions of the heavy and light chains have amino acid sequences as defined, for use in the treatment of an IL-17 mediated disease or disorder, e.g. rheumatoid arthritis.
    Type: Application
    Filed: August 11, 2017
    Publication date: December 14, 2017
    Inventors: Franco E. Di Padova, Hermann Gram, Hans Hofstetter, Margit Jeschke, Jean-Michel Rene Rondeau, Wim Van Den Berg
  • IL-17 antagonistic antibodies
    Patent number: 9765140
    Abstract: An Interleukin-17 (IL-17) binding molecule, in particular an antibody to human IL-17, more preferably a human antibody to human IL-17 is provided, wherein the hypervariable regions of the heavy and light chains have amino acid sequences as defined, for use in the treatment of an IL-17 mediated disease or disorder, e.g. rheumatoid arthritis.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: September 19, 2017
    Assignee: Novartis AG
    Inventors: Franco E Di Padova, Hermann Gram, Hans Hofstetter, Margit Jeschke, Jean-Michel Rene Rondeau, Wim Van Den Berg
  • IL-17 Antagonistic Antibodies
    Publication number: 20150152178
    Abstract: An IL-17 binding molecule, in particular .an antibody to human IL-17, more preferably a human antibody to human IL-17 is provided, wherein the hypervariable regions or the heavy and light chains have amino acid sequences as defined, for use in the treatment of an IL-17 mediated disease or disorder, e.g. rheumatoid arthritis.
    Type: Application
    Filed: February 18, 2015
    Publication date: June 4, 2015
    Applicant: Novartis AG
    Inventors: Franco E. Di Padova, Hermann Gram, Hans Hofstetter, Margit Jeschke, Jean-Michel Rene Rondeau, Wim Van Den Berg
  • IL-17 Antagonistic Antibodies
    Publication number: 20140079719
    Abstract: An IL-17 binding molecule, in particular an antibody to human IL-17, more preferably a human antibody to human IL-17 is provided, wherein the hypervariable regions of the heavy and light chains have amino acid sequences as defined, for use in the treatment of an IL-17 mediated disease or disorder, e.g. rheumatoid arthritis.
    Type: Application
    Filed: November 20, 2013
    Publication date: March 20, 2014
    Applicant: Novartis AG
    Inventors: Franco E. Di Padova, Hermann Gram, Hans Hofstetter, Margit Jeschke, Jean-Michel Rondeau, Wim Van Den Berg
  • IL-17 antibodies
    Patent number: 8617552
    Abstract: An IL-17 binding molecule, in particular an antibody to human IL-17, more preferably a human antibody to human IL-17 is provided, wherein the hypervariable regions of the heavy and light chains have amino acid sequences as defined, for use in the treatment of an IL-17 mediated disease or disorder, e.g. rheumatoid arthritis.
    Type: Grant
    Filed: January 13, 2012
    Date of Patent: December 31, 2013
    Assignee: Novarts AG
    Inventors: Franco E Di Padova, Hermann Gram, Hans Hofstetter, Margit Jeschke, Jean-Michel Rondeau, Wim Van Den Berg
  • IL-17 Antagonistic Antibodies
    Publication number: 20120107325
    Abstract: An IL-17 binding molecule, in particular an antibody to human IL-17, more preferably a human antibody to human IL-17 is provided, wherein the hypervariable regions of the heavy and light chains have amino acid sequences as defined, for use in the treatment of an IL-17 mediated disease or disorder, e.g. rheumatoid arthritis.
    Type: Application
    Filed: January 13, 2012
    Publication date: May 3, 2012
    Inventors: Franco E. Di Padova, Hermann Gram, Hans Hofstetter, Margit Jeschke, Jean-Michel Rondeau, Wim Van Den Berg
  • IL-17 antagonistic antibodies
    Patent number: 8119131
    Abstract: An IL-17 binding molecule, in particular an antibody to human IL-17, more preferably a human antibody to human IL-17 is provided, wherein the hypervariable regions of the heavy and light chains have amino acid sequences as defined, for use in the treatment of an IL-17 mediated disease or disorder, e.g. rheumatoid arthritis.
    Type: Grant
    Filed: February 18, 2010
    Date of Patent: February 21, 2012
    Assignee: Novartis AG
    Inventors: Franco E Di Padova, Hermann Gram, Hans Hofstetter, Margit Jeschke, Jean-Michel Rondeau, Wim Van Den Berg
  • IL-17 antagonistic antibodies
    Patent number: 7807155
    Abstract: An IL-17 binding molecule, in particular an antibody to human IL-17, more preferably a human antibody to human IL-17 is provided, wherein the hypervariable regions of the heavy and light chains have amino acid sequences as defined, for use in the treatment of an IL-17 mediated disease or disorder, e.g. rheumatoid arthritis.
    Type: Grant
    Filed: August 4, 2005
    Date of Patent: October 5, 2010
    Assignee: Novartis AG
    Inventors: Franco E. Di Padova, Hermann Gram, Hans Hofstetter, Margit Jeschke, Jean-Michel Rondeau, Wim Van Den Berg
  • IL-17 ANTAGONISTIC ANTIBODIES
    Publication number: 20100215666
    Abstract: An IL-17 binding molecule, in particular an antibody to human IL-17, more preferably a human antibody to human IL-17 is provided, wherein the hypervariable regions of the heavy and light chains have amino acid sequences as defined, for use in the treatment of an IL-17 mediated disease or disorder, e.g. rheumatoid arthritis.
    Type: Application
    Filed: February 18, 2010
    Publication date: August 26, 2010
    Inventors: FRANCO E. DI PADOVA, HERMANN GRAM, HANS HOFSTETTER, MARGIT JESCHKE, JEAN-MICHEL RONDEAU, WIM VAN DEN BERG
  • IL-17 Antagonistic Antibodies
    Publication number: 20090280131
    Abstract: An IL-17 binding molecule, in particular an antibody to human IL-17, more preferably a human antibody to human IL-17 is provided, wherein the hypervariable regions of the heavy and light chains have amino acid sequences as defined, for use in the treatment of an IL-17 mediated disease or disorder, e.g. rheumatoid arthritis.
    Type: Application
    Filed: August 4, 2005
    Publication date: November 12, 2009
    Inventors: Franco E. Di Padova, Hermann Gram, Hans Hofstetter, Margit Jeschke, Jean-Michel Rondeau, Wim Van Den Berg